REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 133 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $958,649 | -36.0% | 373,015 | +22.5% | 0.00% | – |
Q1 2024 | $1,498,455 | -49.1% | 304,564 | -9.1% | 0.00% | -100.0% |
Q4 2023 | $2,946,277 | -33.4% | 335,185 | -13.1% | 0.00% | 0.0% |
Q3 2023 | $4,423,531 | -53.1% | 385,661 | +3.5% | 0.00% | -50.0% |
Q2 2023 | $9,428,203 | -5.4% | 372,509 | +20.4% | 0.00% | 0.0% |
Q1 2023 | $9,965,097 | +72.6% | 309,379 | -1.1% | 0.00% | +100.0% |
Q4 2022 | $5,772,350 | -30.8% | 312,695 | +1.1% | 0.00% | -50.0% |
Q3 2022 | $8,347,000 | +133.2% | 309,162 | +19.4% | 0.00% | +100.0% |
Q2 2022 | $3,579,000 | -33.2% | 258,964 | -5.7% | 0.00% | 0.0% |
Q1 2022 | $5,354,000 | +18.8% | 274,539 | -0.6% | 0.00% | 0.0% |
Q4 2021 | $4,508,000 | -40.2% | 276,244 | +2.1% | 0.00% | 0.0% |
Q3 2021 | $7,538,000 | +1.4% | 270,553 | +7.9% | 0.00% | 0.0% |
Q2 2021 | $7,433,000 | -29.4% | 250,778 | -33.4% | 0.00% | -50.0% |
Q1 2021 | $10,525,000 | +3.8% | 376,598 | +5.2% | 0.00% | 0.0% |
Q4 2020 | $10,144,000 | +28.8% | 357,922 | +14.2% | 0.00% | 0.0% |
Q3 2020 | $7,877,000 | +15.5% | 313,304 | +12.1% | 0.00% | 0.0% |
Q2 2020 | $6,822,000 | +76.1% | 279,371 | +6.7% | 0.00% | +100.0% |
Q1 2020 | $3,875,000 | -27.2% | 261,858 | -20.1% | 0.00% | 0.0% |
Q4 2019 | $5,320,000 | -61.9% | 327,864 | -69.5% | 0.00% | -75.0% |
Q3 2019 | $13,971,000 | -52.2% | 1,074,706 | -52.3% | 0.00% | -50.0% |
Q2 2019 | $29,233,000 | -19.1% | 2,253,797 | -1.7% | 0.01% | -20.0% |
Q1 2019 | $36,135,000 | -29.4% | 2,292,785 | -9.8% | 0.01% | -37.5% |
Q4 2018 | $51,175,000 | -16.4% | 2,542,242 | +3.1% | 0.02% | 0.0% |
Q3 2018 | $61,245,000 | +14.7% | 2,464,617 | +26.7% | 0.02% | +6.7% |
Q2 2018 | $53,381,000 | -13.9% | 1,944,679 | -3.4% | 0.02% | -11.8% |
Q1 2018 | $62,007,000 | -19.1% | 2,013,232 | -6.1% | 0.02% | -15.0% |
Q4 2017 | $76,672,000 | +38.5% | 2,144,669 | +6.7% | 0.02% | +33.3% |
Q3 2017 | $55,356,000 | +0.8% | 2,009,313 | -3.4% | 0.02% | 0.0% |
Q2 2017 | $54,901,000 | +45.2% | 2,079,562 | +14.4% | 0.02% | +50.0% |
Q1 2017 | $37,810,000 | -5.9% | 1,817,798 | -6.4% | 0.01% | -16.7% |
Q4 2016 | $40,194,000 | +28.9% | 1,941,730 | +1.0% | 0.01% | +33.3% |
Q3 2016 | $31,175,000 | +8.2% | 1,923,108 | -9.2% | 0.01% | 0.0% |
Q2 2016 | $28,812,000 | -16.1% | 2,118,558 | +7.8% | 0.01% | -10.0% |
Q1 2016 | $34,329,000 | -50.0% | 1,966,175 | -2.2% | 0.01% | -52.4% |
Q4 2015 | $68,647,000 | +20.7% | 2,009,567 | +5.1% | 0.02% | +23.5% |
Q3 2015 | $56,887,000 | -3.3% | 1,911,487 | +3.9% | 0.02% | +6.2% |
Q2 2015 | $58,848,000 | +143.8% | 1,840,141 | +58.0% | 0.02% | +166.7% |
Q1 2015 | $24,136,000 | +39.2% | 1,164,294 | +13.8% | 0.01% | +20.0% |
Q4 2014 | $17,337,000 | +968.2% | 1,023,422 | +1118.6% | 0.01% | – |
Q3 2014 | $1,623,000 | -78.2% | 83,984 | -61.6% | 0.00% | -100.0% |
Q2 2014 | $7,444,000 | +1192.4% | 218,854 | +1096.3% | 0.00% | – |
Q1 2014 | $576,000 | – | 18,294 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |